OR WAIT null SECS
March 09, 2021
The expansion will allow Ashland to focus on clinical study projects and commercialization activities.
March 01, 2021
Currently, the facility manufactures products for oral diabetes treatment and will be expanded to increase capacity for these products.
February 25, 2021
The site will house development and GMP production capacities for cell and gene therapies, next-generation vaccines, and biopharmaceuticals, to support clients from early clinical trials through commercialization.
February 24, 2021
The expansion, to be completed in April 2021 aims to increase the CDMO’s viral-vector production capacity in Spain.
February 23, 2021
The new facility is part of Bristol Myers Squibb’s investment into the clinical and commercial manufacturing of cell therapies for patients with aggressive hematological cancers.
Through the acquisition, Catalent will establish pDNA development and manufacturing services at its Rockville, MD, facility and will gain Delphi’s team of R&D and genetic engineering scientists, technicians, and regulatory specialists.
February 18, 2021
The company has completed the expansion of its laboratory facilities to accommodate the development of APIs.
Cascade began production on new facilities to manufacture APIs for clinical and commercial GMP production.
February 16, 2021
The increased services will work in conjunction with the site’s SimpliFiH Solutions first-in-human services, which includes phase-appropriate drug substance and drug product development and manufacturing.
February 11, 2021
The new business services site will house the company’s North American human resource operations, along with certain finance and information technology teams.